Drug Trial Radar · NCT04729751
A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS).
Last checked: Nov 20, 2026Latest source record: Jun 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
27
Actual
Start
Sep 9, 2021
Primary completion
Dec 17, 2024
Study completion Dec 17, 2024
Sponsor
- Lead sponsor
- Mirum Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 28, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 0 days, up to 364 days
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to assess whether the investigational drug maralixibat, is safe and well tolerated in children \<12 months of age with Alagille Syndrome \[ALGS\] or Progressive Familial Intrahepatic Cholestasis \[PFIC\].
Conditions
- Progressive Familial Intrahepatic Cholestasis
- Alagille Syndrome
- Cholestatic Liver Disease
Interventions
MaralixibatDrug
Maralixibat chloride provided in the form of an oral solution (i.e., 5, 10, 15, and 20 mg/mL) * 400 μg/kg maralixibat chloride is equivalent to 380 µg/kg maralixibat free base * 600 μg/kg maralixibat chloride is equivalent to 570 µg/kg maralixibat free base
Primary outcomes
What the sponsor says the trial is designed to measure.
- Frequency of Treatment-emergent Adverse Events [TEAEs]Time frame: From Baseline through to Week 13
Locations
14 sites in 7 countries. Site status is shown where the registry gives one.
Children Hospital LA
Los Angeles, California
University of California - San Francisco
San Francisco, California
Medstar Georgetown University Hospital
Washington D.C., District of Columbia
Ochsner Hospital for Children
New Orleans, Louisiana
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania
Texas Children's Hospital
Houston, Texas
Seattle Children's Hospital
Seattle, Washington
Cliniques Universitaires Saint-Luc
Brussels, Belgium
Sociedade Beneficente de Senhoras - Hospital Sírio-Libanês
São Paulo, Brazil
Hôpital Kremlin Bicêtre
Le Kremlin-Bicêtre, France
Hopital Necker
Paris, France
Consultorio de Joshue David Covarrubias Esquer
Zapopan, Mexico
Instytut Pomnik-Centrum Zdrowia Dziecka
Warsaw, Poland
King's College Hospital
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.